PRESS RELEASE published on 10/31/2025 at 18:52, 6 months 9 days ago Informations privilégiées / Autres communiqués Nomination de Yves Decadt en tant que membre du Conseil d'administration de Poxel renforce la structuration stratégique et commerciale de la société biopharmaceutique au stade clinique. Double expertise scientifique et stratégique apportée par Yves Decadt Conseil D'administration Biopharmaceutique Traitement Poxel Yves Decadt
BRIEF published on 10/16/2025 at 17:56, 6 months 24 days ago Poxel : Résultats financiers 2024 et procédure de redressement judiciaire Résultats Financiers Trésorerie Redressement Judiciaire TWYMEEG® Poxel
BRIEF published on 10/16/2025 at 17:56, 6 months 24 days ago Poxel: 2024 financial results and receivership proceedings Financial Results Treasury TWYMEEG® Poxel Judicial Recovery
PRESS RELEASE published on 10/16/2025 at 17:51, 6 months 24 days ago Informations privilégiées / Communiqué sur comptes, résultats Poxel annonce ses résultats financiers 2024 avec des redevances positives pour TWYMEEG® et une procédure de redressement judiciaire en cours, plans de continuité et perspectives de ventes au Japon Résultats Financiers Redressement Judiciaire Poxel Redevances Ventes Japon
PRESS RELEASE published on 10/16/2025 at 17:51, 6 months 24 days ago Inside Information / News release on accounts, results Poxel reports financial results for full year 2024, including positive net royalties and governance changes. Updates on operational and financial status provided. Commercial momentum for TWYMEEG® in Japan. Cash position and financing details shared Financial Results Cash Position Governance Changes TWYMEEG® Poxel
BRIEF published on 08/08/2025 at 17:50, 9 months 1 day ago POXEL Entame une Procédure de Redressement Judiciaire Maladies Métaboliques Redressement Judiciaire Cotation Euronext Période D'observation Stéatohépatite
BRIEF published on 08/08/2025 at 17:50, 9 months 1 day ago POXEL Begins Judicial Reorganization Proceedings Metabolic Diseases Euronext Listing Judicial Recovery Steatohepatitis Observation Period
PRESS RELEASE published on 08/08/2025 at 17:45, 9 months 1 day ago Informations privilégiées / Autres communiqués POXEL annonce l'ouverture d'une procédure de redressement judiciaire avec reprise de cotation de l'action le 11 août 2025. La société biopharmaceutique explore ses options pour poursuivre ses activités Biopharmaceutique Cotation Redressement Judiciaire Procédure Poxel
BRIEF published on 07/29/2025 at 20:21, 9 months 11 days ago Poxel Initiates Reorganization Amid Financial Struggles Creditors Reorganization Insolvency Corporate Changes Poxel
BRIEF published on 07/29/2025 at 20:21, 9 months 11 days ago Poxel entame une réorganisation en raison de difficultés financières Créanciers Reorganisation Insolvabilité Poxel Changements D'entreprise
Published on 05/09/2026 at 01:30, 1 day 14 hours ago Star Copper Announces Agreement with Zimtu Capital Corp.
Published on 05/09/2026 at 00:00, 1 day 16 hours ago Onco-Innovations Progresses Toward IND Preparation as Nucro-Technics Commences Bioanalysis for PNKP Inhibitor Technology
Published on 05/10/2026 at 16:05, 18 minutes ago RingConn Gen 3 Smart Ring Opens for Pre-Order: Bringing Vascular Insights to Effortless Everyday Wear
Published on 05/10/2026 at 14:00, 2 hours 23 minutes ago MBC GROUP DELIVERS RESILIENT 1Q 2026 PERFORMANCE ANCHORED BY STRONG MBC SHAHID GROWTH
Published on 05/10/2026 at 11:45, 4 hours 38 minutes ago Hisense Kicks Off FIFA World Cup 2026™ Campaign, Bringing Fans Closer Through "Innovating a Brighter Life"
Published on 05/09/2026 at 19:05, 21 hours 18 minutes ago LONGi EcoLife Series Module Top TaiyangNews Global Ranking, Ushering in the "25%+" Era of Photovoltaic Efficiency
Published on 05/08/2026 at 20:38, 1 day 19 hours ago EQS-Adhoc: thyssenkrupp nucera AG & Co. KGaA: Preliminary Figures for Q2/6M 2025/26; Order Intake Above Expectations and Previous Year ; Sales and Earnings below Market Expectations
Published on 05/07/2026 at 19:15, 2 days 21 hours ago 2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 2 days 21 hours ago Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 2 days 21 hours ago Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 2 days 21 hours ago Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 2 days 21 hours ago ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL